Founded in 1974, Zhejiang Yongning Pharmaceutical Co., Ltd (formerly a state-owned factory known as Zhejiang Yongning Pharmaceutical Factory) covers an area of 130,000 square meters, and has 900 employees. It is a national key high-tech enterprise that integrates pharmaceutical research and development with production and sales, and also a pioneer who manufactures cephalosporin side-chain products in China. The company specializes in five categories of products with more than 100 varieties and specification, including chemical pharmaceutical intermediates, API, finished dosages, Chinese patent medicines, and health-care products. Our company has been granted Chinese new GMP certificates and some products have been approved by U.S.FDA, Japanese PMDA and South Korean KFDA. Cefotiam hydrochloride has been approved as the reference standard of USP by USP authority.
We have applied for 53 domestic and international patents, of which 38 have been authorized, including 3 US patents. Yongning has 6 kinds of independent intellectual property, 2 brand certificates for National Protected Traditional Chinese Medicines and 10 invention patents.
Based on good quality and service, our products are popular nationwide and have been exported to Asian, American and European markets, such as Japan, Korea, Switzerland, Italy, Mexico, Brazil, Ukraine, Egypt, India, Pakistan, etc. In the meantime, they are widely acknowledged and appreciated by customers around the world.
more >
Year of Establishment:
1974
Total Assets(USD):
choose not to disclose
Total Number of Staff:
more than 500
Main Competitive Advantages:
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Quality Service
Other Competitive Advantages:
Part of our products have been approved by USA FDA, Japan PMDA or South Korea FDA.
Patents and Copyrights:
Yongning Pharma has more than 100 products, including 7 kinds with independent intellectual property right and a Protected National Chinese medicine. Yongning Pharma has obtained 27 patents at home and aboard, including 5 international patents. Ten among
Business Type:
Manufacturer,Trading Company
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Other Competitive Advantages:
Part of our products have been approved by USA FDA, Japan PMDA or South Korea FDA.
Patents and Copyrights:
Yongning Pharma has more than 100 products, including 7 kinds with independent intellectual property right and a Protected National Chinese medicine. Yongning Pharma has obtained 27 patents at home and aboard, including 5 international patents. Ten among